What did @kmartfit actually say?
The core claim is simple: drawing and injecting testosterone with the same needle will dull the tip, cause more pain, and raise infection risk. The creator also says that any TRT clinic failing to send two different needle gauges, typically a 21 for drawing and a 25 for injecting, is a "huge red flag" that the clinic is exploitative. The video ends with a soft pitch for their own clinic.
To be fair, the clinical advice here is largely sound. The two-needle approach is a real, widely taught practice in self-injection training. But the framing deserves scrutiny, especially the leap from "they didn't send two needles" to "they're trying to take advantage of you."
Does the science back this up?
Yes, with some nuance. The physics are real: a needle tip deforms measurably after passing through a rubber stopper. Studies on insulin self-injection have documented this directly.
A 2012 study by Kreugel et al. in Diabetes Research and Clinical Practice found that needle reuse, even a single use prior to injection, increased pain scores and caused visible tip deformation under electron microscopy. While that research focused on subcutaneous insulin needles, the mechanical principle applies equally to intramuscular testosterone injections. Drawing through a rubber vial stopper bends the tip, and a bent tip drags through tissue rather than slicing cleanly.
On infection risk, the claim is biologically plausible but harder to pin to direct evidence. Drawing from a vial can introduce particulate matter or micro-contaminants to the needle tip. Changing needles before injection eliminates that vector entirely. The CDC's injection safety guidelines support using a fresh needle for patient injection, which aligns with this practice even if it doesn't use the exact framing the creator uses.
What did they get wrong (or right)?
They got the core technique right. Using separate needles for drawing and injecting is legitimate, evidence-adjacent practice, and the gauge recommendations, 21 for drawing, 25 for injecting into muscle, are reasonable standard choices for testosterone cypionate or enanthate, which are viscous oils.
What they oversimplified is the "red flag" framing. Needle supply varies by clinic, pharmacy, state regulations, and insurance coverage. Some compounding pharmacies ship medications without injection supplies at all, relying on patients to source them locally. That is not automatically predatory. The jump from a supply logistics gap to "they just want your money" is a stretch that isn't supported by any clinical standard or regulatory requirement the creator cites, because they cite none.
The pitch at the end also deserves a flag. Recommending a specific clinic in the same breath as clinical advice is a conflict of interest, and viewers should weigh the advice knowing the creator is monetizing referrals.
What should you actually know?
If you are self-administering testosterone injections, the two-needle technique is worth following. Use a wider gauge needle, typically 18-21, to draw the oil from the vial efficiently, then swap to a finer gauge needle, typically 23-25, for the actual injection. This keeps the injection needle sharp, which reduces tissue trauma and, by most clinical accounts, pain.
Needle gauge choice also depends on injection site and body composition. Ventrogluteal and vastus lateralis sites in average-BMI patients can typically accommodate a 1-inch 25-gauge needle. Dorsogluteal injections in patients with more subcutaneous fat may require a longer needle to reach muscle. That is a conversation to have with your prescribing provider, not a TikTok comment section.
As for clinic quality signals: supply kits, while convenient, are not a reliable proxy for clinical competence. Look at whether your provider is reviewing labs, adjusting dosing based on bloodwork, and available for clinical questions. Those are the real markers of a clinic that cares about outcomes.